Technical Analysis for MYO - Myomo Inc.

Grade Last Price % Change Price Change
D 3.74 2.19% 0.08
MYO closed up 2.19 percent on Friday, November 1, 2024, on approximately normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline.
Earnings due: Nov 6
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
Crossed Above 200 DMA Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze Started Range Contraction 0.00%
Inside Day Range Contraction 0.00%
Fell Below 20 DMA Bearish 2.19%
Fell Below 200 DMA Bearish 2.19%
Fell Below 50 DMA Bearish 2.19%
180 Bearish Setup Bearish Swing Setup 2.19%

   Recent Intraday Alerts

Alert Time
Possible Inside Day about 19 hours ago
200 DMA Resistance about 23 hours ago
Rose Above 200 DMA about 23 hours ago
20 DMA Resistance about 23 hours ago
10 DMA Resistance about 23 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Myomo Inc. Description

Myomo, Inc. is a commercial stage medical robotics Company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis. Based on patented technology developed at MIT and the Company, Myomo develops and markets the MyoPro® product line of lightweight, non-invasive, powered arm braces to restore function in the paralyzed or weakened arms and hands of individuals that have suffered a stroke, spinal cord or nerve injury such as brachial plexus injury, or other neuromuscular disability such as amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS). It is provided through clinical relationships with VA medical centers, leading rehabilitation hospitals, and Orthotics and Prosthetics (“O&P”) practices. Several hundred have been successfully used by patients. It is the only device that, sensing a patient’s own neurological signals through non-invasive sensors on the arm, can restore their ability to use their arms and hands so that they can return to work, live independently and reduce their cost of care. Myomo is headquartered in Cambridge, Massachusetts, with sales and clinical professionals across the U.S. For more information, please visit www.myomo.com.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Organ Systems Disability Robotics Neurological Disorders Multiple Sclerosis Stroke Amyotrophic Lateral Sclerosis Prosthetics Nerve Urological Disorders Orthopedics Podiatry Spinal Cord Skeletal System Neurotrauma

Is MYO a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.64
52 Week Low 1.41
Average Volume 131,232
200-Day Moving Average 3.70
50-Day Moving Average 3.90
20-Day Moving Average 3.82
10-Day Moving Average 3.79
Average True Range 0.18
RSI (14) 45.36
ADX 11.17
+DI 15.15
-DI 20.91
Chandelier Exit (Long, 3 ATRs) 3.53
Chandelier Exit (Short, 3 ATRs) 4.12
Upper Bollinger Bands 3.99
Lower Bollinger Band 3.65
Percent B (%b) 0.25
BandWidth 8.86
MACD Line -0.03
MACD Signal Line -0.03
MACD Histogram -0.0016
Fundamentals Value
Market Cap 104.24 Million
Num Shares 27.9 Million
EPS -0.49
Price-to-Earnings (P/E) Ratio -7.63
Price-to-Sales 5.49
Price-to-Book 9.30
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.00
Resistance 3 (R3) 4.00 3.91 3.95
Resistance 2 (R2) 3.91 3.85 3.91 3.94
Resistance 1 (R1) 3.83 3.81 3.87 3.83 3.92
Pivot Point 3.74 3.74 3.77 3.74 3.74
Support 1 (S1) 3.66 3.68 3.70 3.65 3.56
Support 2 (S2) 3.57 3.64 3.57 3.54
Support 3 (S3) 3.49 3.57 3.53
Support 4 (S4) 3.48